Columbia Financial, Inc. Announces Receipt of Stockholder and Depositor Approvals of Pending Second Step Conversion and Updated Results of Subscription Offering

Columbia Financial (CLBK) announced stockholder approval of a mutual-to-public conversion for Columbia Bank, effective via a Plan of Conversion and Reorganization, with the acquisition of Northfield Bancorp approved to occur simultaneously. Depositors also approved the conversion at a separate Columbia Bank MHC members meeting. Overall, this is a corporate restructuring and M&A event likely to be modestly market-moving for the company rather than a broad sector catalyst.

Analysis

CLBK’s real value creation is not the transaction itself but the capital-structure reset: once the MHC constraint is gone, management should have more flexibility on buybacks, branch rationalization, and future M&A, which can support a higher ROE multiple over 6-18 months. The catch is that the market usually does not pay up until it sees pro forma tangible book dilution, CET1, and deposit-cost implications; absent that disclosure, the move is more about optionality than near-term EPS accretion.

For competitors, the combined franchise likely gets incrementally more aggressive on pricing in the Mid-Atlantic, which can pressure smaller community banks and mutuals that rely on similar deposit bases. That matters more for regional-bank valuation dispersion than for outright sector beta: if CLBK can show stable deposit betas and low integration costs, it can outperform KRE peers that lack a restructuring catalyst. If not, the market may simply classify this as another capital-consuming bank consolidation story with limited immediate payoff.

The contrarian read is that approval is a necessary step, not a monetizable catalyst. Consensus may be overestimating synergy timing and underestimating the friction from conversion expenses, systems integration, and regulatory capital constraints, all of which can suppress returns for several quarters. The thesis is falsified if the next filing shows meaningful tangible book dilution, weaker-than-expected CET1, or management lowers post-close efficiency targets; in that case, any re-rating should be faded rather than bought.

Key Decisions for Investors

• No immediate outright long in CLBK on approval alone; wait for pro forma close materials and only buy on a pullback if the stock trades below ~0.9x pro forma tangible book or if the selloff creates >5% downside to event value.
• If a clean merger-arb spread becomes visible in NFBK after exchange terms are confirmed, consider a modest long NFBK / short CLBK position with a 60-90 day horizon; avoid sizing aggressively until regulatory timing is clearer.
• If taking any CLBK long exposure, hedge with KRE rather than a single-name short; the trade is a relative re-rating story, not a broad bank beta bet, and should be monitored into the next earnings update.
• Set a watch item for pro forma CET1, deposit beta, and tangible book dilution. If any of those come in materially worse than peers, exit the thesis quickly because the conversion upside will be overwhelmed by integration and funding-cost drag.